< Back to previous page
Researcher
An Goris
- Disciplines:Immunology
Affiliations
- Laboratory for Neuroimmunology (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Apr 2004 → 31 Dec 2011 - Immunobiology (Rega Institute) (Lab)
Member
From1 Oct 1999 → 31 Mar 2004
Projects
31 - 40 of 42
- A role for B cells in immunomodulatory treatment of multiple sclerosis.From1 Jan 2015 → 31 Dec 2015Funding: Private funding of national origin - undefined
- Multiple sclerosis: from genetic and immunological profile to personalized medicine.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- The immunogenetic basis of progression in MS.From1 Jan 2015 → 31 Dec 2017Funding: Foundations, funds and other with scientific goal
- Heterogeneity in multiple sclerosis. Insights from imaging, immunology and geneticsFrom1 Oct 2014 → 25 Sep 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Somatic mutations explain missing risk of multiple sclerosis.From1 Oct 2014 → 30 Sep 2017Funding: BOF - Doctoral projects, BOF - Concerted Research Project from 1994
- Magnetisation transfer ratio (MTR) as a surrogate marker for disease heterogeneity in multiple sclerosis (MS).From1 Jan 2013 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
- GALC as the first myelin-associated MS risk factor?From1 Jan 2013 → 31 Dec 2013Funding: Nonprofit institution or equivalents
- Multiple sclerosis - How common variants influence disease phenotype and rare variants trigger onset of diseaseFrom27 Aug 2012 → 6 Dec 2016Funding: Own budget, for example: patrimony, inscription fees, gifts
- From genotype to immunophenotype in multiple sclerosis.From17 Jul 2012 → 17 Jul 2014Funding: Foundations, funds and other with scientific goal
- Multiple sclerosis: from genotype to phenotype.From1 Oct 2011 → 30 Sep 2016Funding: BOF - Concerted Research Project from 1994
Publications
1 - 10 of 111
- A targeted sequencing extension for transcript genotyping in single-cell transcriptomics(2023)
Authors: Margaux David, An Goris, Bénédicte Dubois
- Exploring genetic clustering of severity markers to identify groups with reduced heterogeneity in multiple sclerosis(2023)
Authors: An Goris
Pages: 479 - 480 - The role of glial cells in sALS and C9orf72 HRE-mediated ALS(2023)
Authors: Pegah Masrori, Philip Van Damme, An Goris
- Locus for severity implicates CNS resilience in progression of multiple sclerosis(2023)
Authors: Bénédicte Dubois, An Goris
Pages: 329 - 331 - Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198.(2023)
Authors: Jeroen Blommaert, Charlotte Sleurs, Sigrid Hatse, An Goris, Michel Koole, Ann Smeets, Koen Van Laere, Stefan Sunaert, Sabine Deprez
Pages: 3091 - Genetics of multiple sclerosis: lessons from polygenicity(2022)
Authors: An Goris
Pages: 830 - 842 - Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies(2022)
Authors: Marijne Vandebergh, Bénédicte Dubois, An Goris
Pages: 4565 - 4574 - Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study(2022)
Authors: Marijne Vandebergh, Bénédicte Dubois, An Goris
- From susceptibility to heterogeneity in multiple sclerosis: insights from genetic epidemiology(2022)
Authors: Marijne Vandebergh, An Goris, Bénédicte Dubois
- Natural killer cells in multiple sclerosis: entering the stage.(2022)
Authors: Jarne Beliën, An Goris, Patrick Matthys